Open AccessPontine demyelination as a late complication of resolved mild COVID-19 infection
Author(s) -
Nouran Eshak,
Mahmoud Abdelnabi,
R. M. Jacob,
Drew Payne
Publication year - 2021
Publication title -
the southwest respiratory and critical care chronicles
Language(s) - English
Resource type - Journals
ISSN - 2325-9205
DOI - 10.12746/swrccc.v9i41.947
Subject(s) - anosmia , dysgeusia , medicine , covid-19 , headaches , complication , encephalitis , pathology , surgery , disease , virology , virus , infectious disease (medical specialty) , adverse effect , outbreak
Previous case reports have demonstrated COVID-19 related neurotropism. Neural infection may result from trans-lamina cribrosa invasion that allows COVID-19 to reach the brain through the olfactory tract. A wide range of symptoms from headaches, anosmia, dysgeusia to neuropathy, encephalitis, cerebrovascular stroke, and rarely demyelination has been reported. Here, we report a case of pontine demyelination causing generalized weakness as a rare neurological complication in a COVID-19 survivor. Our case highlights that even mild and moderate COVID-19 infection can have late neurological sequelae.
Keywords: COVID-19, demyelination, neurological complications, corticosteroids